Leads Biolabs is a clinical-stage biotechnology company 
dedicated to the discovery, development, and commercialization of innovative therapies 
to address underserved medical needs in oncology, autoimmune, and other severe diseases both in China and globally.

  • 2012
    YEAR FOUNDED
  • 80%+
    R&D PERSONNEL
  • 20+
    PIPELINE ASSETS
  • 20
    PATENTS​​​​​​​ GRANTED
Front-Runner in Next-Gen Immuno-Oncology Treatments
  • Multiple Clinical Programs
    For cancer patients who do not respond adequately to existing immunotherapies
  • Differentiated Pipeline
    Uniquely designed to form an ecosystem of comprehensive therapeutics
  • Integrated Capabilities
    Across early discovery, clinical development, CMC and business development
LATEST NEWS

FDA Granted Orphan Drug Designation of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs, for Treatment of Neuroendocrine Cancer

NANJING, China, November 22, 2024 -- Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as "Leads Biolabs") announced that LBL-024, an anti-PD-L1/4-1BB bispecific antibody independently developed by the company with global intellectual property rights for the treatment of neuroendocrine cancer

no photo
Aditum Bio and Leads Biolabs Announce the Formation of Oblenio Bio to Develop a Tri-Specific T-Cell Engager for Autoimmune Disorders

Leads Biolabs grants Oblenio Bio an exclusive option to license LBL-051, a first-in-class CD19xBCMAxCD3 tri-specific T-cell engager antibody

no photo
Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma

NANJING, China, November 1st, 2024--Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as "Leads Biolabs") announced that LBL-034, a humanized bispecific T-cell engaging antibody targeting both GPRC5D and CD3 which is independently developed by Leads Biolabs with global intellectual property r

no photo

Platforms

Collaborations

Careers

Contact Us
Leads Biolabs © Nanjing Leadsbiolabs  Co., Ltd. | Su ICP No. 18069235​​​​
Privacy Policy